Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT02308865 |
Date of registration:
|
02/12/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Early Palliative Care in Metastatic Lung Cancer in Northern France
IMPAQ |
Scientific title:
|
Impact of Early Palliative Care on Quality of Life and Survival of Patients With Non-small-cell Metastatic Lung Cancer in Northern France |
Date of first enrolment:
|
October 17, 2014 |
Target sample size:
|
71 |
Recruitment status: |
Terminated |
URL:
|
https://clinicaltrials.gov/show/NCT02308865 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
France
| | | | | | | |
Contacts
|
Name:
|
Licia Touzet, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
University Hospital, Lille |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Being diagnosed with non-small cell lung cancer
- Proven histologically
- Metastatic proven imaging (MRI, CT Scanner, PET scan)
- Stage IV (any T, any N, M1)
- prior to secondary chemotherapy treatment.
- Age> 18 years
- PS =2
- Patient able to understand the nature, purpose and methodology of the study
- signed Informed consent
Exclusion Criteria:
- Age <18 years
- Patient already supported by palliative care
- Patient with an activating EGFR mutation or EML4-ALK rearrangement or ROS1 gene
translocation
- Patient under trusteeship / guardianship
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Lung Cancer Metastatic
|
Intervention(s)
|
Other: multi disciplinary palliative care monthly consultations
|
Primary Outcome(s)
|
quality of life
[Time Frame: 12 weeks]
|
Secondary Outcome(s)
|
QUALITY OF LIFE
[Time Frame: 12 and 21 weeks]
|
EVENTS
[Time Frame: 14 days before deaths]
|
SURVIVAL
[Time Frame: from baseline]
|
Secondary ID(s)
|
2013_70
|
2014-A00514-43
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|